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Abstract
Introduction: Chemotherapy may induce deleterious effects in normal tissues, leading to organ damage. Direct vascular
injury is the least characterized side effect. Our aim was to establish a real-time, in vivo molecular imaging platform for
evaluating the potential vascular toxicity of doxorubicin in mice.
Methods: Mice gonads served as reference organs. Mouse ovarian or testicular blood volume and femoral arterial blood
flow were measured in real-time during and after doxorubicin (8 mg/kg intravenously) or paclitaxel (1.2 mg/kg)
administration. Ovarian blood volume was imaged by ultrasound biomicroscopy (Vevo2100) with microbubbles as a
contrast agent whereas testicular blood volume and blood flow as well as femoral arterial blood flow was imaged by pulse
wave Doppler ultrasound. Visualization of ovarian and femoral microvasculature was obtained by fluorescence optical
imaging system, equipped with a confocal fiber microscope (Cell-viZio).
Results: Using microbubbles as a contrast agent revealed a 33% (P,0.01) decrease in ovarian blood volume already 3
minutes after doxorubicin injection. Doppler ultrasound depicted the same phenomenon in testicular blood volume and
blood flow. The femoral arterial blood flow was impaired in the same fashion. Cell-viZio imaging depicted a pattern of
vessels’ injury at around the same time after doxorubicin injection: the wall of the blood vessels became irregular and the
fluorescence signal displayed in the small vessels was gradually diminished. Paclitaxel had no vascular effect.
Conclusion: We have established a platform of innovative high-resolution molecular imaging, suitable for in vivo imaging of
vessels’ characteristics, arterial blood flow and organs blood volume that enable prolonged real-time detection of
chemotherapy-induced effects in the same individuals. The acute reduction in gonadal and femoral blood flow and the
impairment of the blood vessels wall may represent an acute universal doxorubicin-related vascular toxicity, an initial event
in organ injury.
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Introduction
Chemotherapy may exert deleterious effects on normal tissues,
leading to organ damage. It is now apparent that chemotherapy
administration contributes to adverse vascular conditions that lie
at the basis of a heterogeneous group of disorders. The precise
pathogenesis of these toxic effects has not been elucidated.
Chemotherapy-induced vascular toxicity may cause acute cardio-
vascular complications that could be the initiation seed for
progression of long-term diseases such as atherosclerosis and for
increased risk of vascular events. The potential vascular insult
characteristics of several chemotherapeutic agents have been
studied, and doxorubicin was shown to stimulate apoptosis in
endothelial cells [1–3].
Doxorubicin, an anthracycline that is a cornerstone of many
chemotherapeutic protocols, is used for treating a wide spectrum
of malignancies. Cardiomyocytes and endothelial cell-lines
exposed to doxorubicin in vitro, exhibited a dose-related apoptosis
that may occur due to generation of free radicals [4–9].
Experiments in intact aortic rings demonstrated that acute
exposure (,30 minutes) to doxorubicin results in generation of
oxygen radicals in endothelial cells via a flavoprotein containing
oxido-reductase [10]. Organ culture studies as well as mammalian
models have also shown that doxorubicin exerts harmful effects on
vascular endothelium, leading to impaired vasodilatory response of
arteries [1–3,10,11]. It appears that administration of a single dose
of doxorubicin in rabbits is associated with rapid deterioration of
endothelium-dependent and independent vascular responses.
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associated with acute reduction of flow-mediated dilatation in
the brachial arteries and of nitric oxide level in the plasma [11].
High-frequency ultrasound with enhanced contrast agents
enables in vivo imaging and analysis of blood perfusion. Micro-
bubbles are a contrast agent that enhances the acoustic signal of
blood in the circulation; they are small enough to move freely
through the bloodstream, and are used as markers for visualization
and quantification of regional microvasculature [12,13]. Fibred
confocal fluorescence microscopy (FCFM) was designed for in vivo
imaging of fluorescent signals in living animals. The FCFM with
its optical mini-probes enables in vivo fluorescent visualization of
microvasculature with a minimal invasive intervention [14].
We have set up a platform of live, high-resolution molecular
mice imaging, suitable for capturing vessels’ characteristics,
arterial blood flow and organs blood volume. This imaging setup
enables us to detect acute, real-time, treatment-induced effects
within the same individuals and follow them over a period of time.
Using both imaging tools, we could observe that doxorubicin had
an effect on blood vessels already 3 minutes after administration.
The acute reduction (of 33% from baseline values) in gonadal
(ovarian or testicular) and femoral blood flow and the impairment
of the blood vessels wall may represent an acute universal
doxorubicin-related vascular toxicity, an initial event in organ
injury.
Materials and Methods
Animal care and all experiments were in accordance with
institutional guidelines and were approved by the Institutional
Animal Care and Use Committee, Sackler Faculty of Medicine,
Tel-Aviv University, ID number M-09049.
Animals
ICR mature male and female mice (7–8 weeks old; Harlan
Laboratories, Jerusalem, Israel) were housed in air conditioned,
light controlled animal facilities of the Sackler faculty of Medicine
in Tel-Aviv University.
Chemotherapy
Doxorubicin (8 mg/kg, Adriamycin; Teva, Israel), paclitaxel
(1.2 mg/kg, Medexel; Taro, Israel) or saline were injected
intravenously (IV) into the tail vein at a volume of 100 ml.
Ultrasound imaging
The molecular bioimaging platform enables real-time evalua-
tion of the same individual over time, and hence each mouse
serves as its own control.
Preparing the animals for imaging. Mice were
anesthetized with isoflurane (Nicholas Piramal India Limited,
India; 5% in oxygen for induction, 1–3% for maintenance at a rate
of 1liter/minute). Hemodynamic measurements were performed
continuously throughout the experiments. Mice were positioned
on a MousePad (part of the VisualSonics Vevo Integrated Rail
System II) equipped with integrated heater and ECG electrodes
(IndusInstruments,Houston,TX). 4 legs were secured to ECG
pads, with mediation of electrode cream (Signa cream; Parker
Laboratories Inc., Fairfield, NJ, USA), to allow continuous
monitoring of respiration rate. Respiration rate was maintained
constant (varied between 20–40 breaths/minute in the cohort),
body temperature was maintained at 37.5uC.
A 30-gauge, 1/2-inch needle attached to 1 ml syringe was
inserted into the tail vein for IV administration of both contrast
agent and either doxorubicin, paclitaxel or saline. Dorsal and
groin fur was removed by a depilatory cream (Veet, Reckitt
Benckiser, Bristol, UK). Pre-warmed ultrasound gel (Aquasonic,
Parker Laboratories Inc, Fairfield, NJ, USA) was used as a
coupling agent between the ultrasound scan-head and the skin.
Mice gonads or femoral arteries were viewed by the color mode
of the high-resolution ultrasound (Vevo 2100; Visual Sonics,
Toronto, Canada), with the transducer (MicroScan MS 550D; 22–
55 MHz) held immobilized, in-position by the VisualSonics Vevo
Integrated Rail System II.
To reduce variability, image parameters remained constant
throughout the experiment (i.e., focus and depth optimized for
each animal at the beginning of the experiment and the point of
monitoring was fixed through the entire experiment). The same
scan plane approximation, determined by anatomic markers, was
used in all experiments.
Ultrasound contrast imaging of the ovarian blood
volume. Gas-filled (nitrogen and perflurobutane) microbubbles
(Definity, Lantheus Medical Imaging, MA, USA; 1.1–3.3 mm
diameter; maximum concentration of 1.2610
10 microbubbles/
ml), an ultrasound contrast agent, were injected IV into mice.
Prior to each imaging, the microbubbles were reconstituted by a
15 second gentle stir, diluted with saline (1:1) and injected IV into
the tail vein in 80 ml bolus. Ovaries were viewed at the contrast
mode and their blood volume, which was reflected by the
microbubbles intensity, was determined by the appropriate
VisualSonics software. The baseline rate of ovarian blood
volume was quantified after a short stabilization period (at which
the mouse was positioned) by analyzing the intensity of the
contrast agent during a 50 second image recording period
(referred to as ‘‘cine loop’’), as previously described [12,13].
Mice were then injected IV with either doxorubicin (n=7),
paclitaxel (n=8) or saline (n=7; control). Rate of ovarian blood
volume was re-quantified 3, 10 and 20 minutes after the IV
injection of either chemotherapy or saline. The circulating
microbubbles were destroyed between injections by the pulse-
wave (PW) Doppler mode (100% power).
PW Doppler measurement of blood flow in testicular or
femoral vessels. Testicular blood volume and flow as well as
femoral arterial blood flow was viewed at the PW Doppler mode
using the appropriate VisualSonics software. Following a short
stabilization period, a baseline femoral or testicular arterial blood
flow was recorded by the PW Doppler mode during a 50 second
cine loop and quantified by analyzing the Velocity-Time Integral
(VTI) [15-18]. When the PW Doppler mode curve is integrated, it
yields a VTI that indicates the distance the blood travels during a
certain cardiac circle. Mice were then injected IV with either
doxorubicin (n=12, n=number of imaged arteries), paclitaxel
(n=14) or saline (n=10) for recording femoral arteries blood flow,
or doxorubicin (n=8) or saline (n=7) for recording testicular
artery blood flow. The arterial blood flows were monitored
continuously for 20 minutes, and recorded and analyzed at various
time points post injection. To note, this methodology was not
applicable for measuring ovarian blood flow technically due to the
deep location and size of the ovaries.
Image analysis. Acquired contrast (ovarian blood volume)
and PW Doppler (testicular and femoral arterial blood flow) cine
loops were digitally stored and pooled for off-line analysis. Analysis
of all four ovary blood volume cine loops captured for each mouse,
was performed at a fixed region of interest (ROI), and the data was
presented as an Excell curve, provided by the VisualSonics
software. A trend line (mean of 20 points) was added to each curve
and the D between the microbubbles ‘‘first pass’’ value (highest
point) and the reference value (lowest point) was calculated.
Analysis of the femoral arterial blood flow and testicular blood
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automatic frequency trace to each cine loop and acquiring 2–4
regions of VTI, in accordance to the breathing signal. Values of
post-treatment imaging (calculated proportionally for microbubbles
cine loops; mean value for PW Doppler VTIs) were normalized
according to pre-treatment imaging values of each mouse (defined
as 100%). Saline-injected mice were standardized to 100% as a
reference to chemotherapy-injected mice. Non normalized values
are presented in the supplement.
Fibred confocal fluorescence microscopy (FCFM) imaging
FCFM (Cell-viZio; Mauna Kea Technologies, Paris, France)
was developed for in situ and in vivo imaging [14,19]. Its technology
is based on the excitation of either intrinsic or extrinsic fluorescent
molecules in the examined tissue. The Cell-viZio is composed of a
laser scanning unit LSU-488 (FibroScan) that uses a laser source
with a wavelength of 488 nm and of a ProFlex microprobe
(mini0/30). FCFM imaging of ovarian or femoral vessels during
and following doxorubicin, paclitaxel or saline administration was
performed in mice under general anesthesia (100 mg/kg ketaset,
Fort Dodge Animal Health, IA, USA and 6 mg/kg XYL-M2,
Biove Laboratories, France). For in vivo ovary imaging the
abdominal skin above the ovary was incised. For femoral arterial
vessels imaging, the skin was incised below the groin. FITC-
dextran at a volume of 100 ml (10 mg/ml; FD2000S, MW
2000000 Dalton; Sigma) was administered IV to facilitate the
FCFM visualization of the microsvascular network. A 488-nm
wavelength laser was used for all dynamic observations. The
emitted fluorescence was filtered (500 to 650 nm) prior to
detection by a detector housed in the main unit. The images
were then reconstructed and viewed on a real-time display at
12frames/second. A baseline recording of the flow was obtained
during a short stabilization period, following mouse positioning
and before an IV injection of doxorubicin (n=19), paclitaxel
(n=7) or saline (n=9). FITC-dextran flow was monitored
continuously for 20 minutes after the injections. Blood vessels
were categorized according to their diameter, and were defined a
priori as small (,15 mm), and large (.15 mm).
Statistical analysis
SPSS 10.0 software (SPSS Inc, Chicago, IL, USA) was used for
statistical analysis. T-TEST with two-tailed distribution and two-
sample unequal variance was employed for assessing the degree of
change in the ovarian blood volume experiment. Two-way
analysis of variance (ANOVA) with repeated measures was
employed for assessing the degree of change in blood flow in the
femoral arterial blood flow or testicular blood flow experiment.
Results were considered statistically significant at P,0.01. Results
are given as mean6SD.
Results
In vivo ovarian ultrasound imaging
The Vevo 2100 ultrasound depicted detailed images of mouse
ovarian blood volume before and after administration of saline
(Fig. 1A b-e, green) or chemotherapeutic agents (Fig. 1A g-j, l-o,
green), indicating a 33% decrease in ovarian blood volume already
3 minutes after doxorubicin injection (Fig. 1B; P,0.01) that was
partially recovered 10 and 20 minutes after treatment to a degree
that was not statistically different from the ovarian blood volume
in control mice at the same time points (Fig. 1B). The difference in
ovarian blood volume between paclitaxel injected mice and
control mice was not statistically significant at any time points
(Fig. 1B).
In vivo testicular and femoral ultrasound imaging
The effect of doxorubicin or paclitaxel on the testicular blood
flow and the femoral arterial blood flow was assessed by measuring
VTI with the PW Doppler. Both the testicular and the femoral
vessels depicted the same fashion: A constant rapid fall in the
testicular blood flow (40% decrease, P,0.01) and in the arterial
femoral blood flow (23% decrease, P,0.01) was evident already 3
minutes after doxorubicin administration and lasted even 20
minutes after treatment (Fig. 2A+B). Paclitaxel had no effect on
femoral arterial blood flow (Fig. 2B). Non-normalized figures are
presented in figures S1B, S2A, S2B.
Imaging of ovarian and femoral microvasculature
We have characterized, the network of the ovarian and femoral
blood vasculature, according to vessels diameter (small, ,15 mm; large,
.15 mm), by FCFM in mice injected with FITC-dextran. Small vessels
became narrower approximately 2–5 minutes after administration of
doxorubicin and continued so until a complete disappearance of the
FITC-dextran fluorescent signal at around 8 minutes after treatment
( F i g .3 Ae - h ,a r r o w s ;V i d e oS 1 ) .I ns e v e r a lm i c e ,h a z i n e s so ft h e
perivascular region could be spotted, a few seconds after doxorubicin
administration (Fig. 3B g,h, arrows; Video S2), pointing at a possible
leakage from the blood vessel to the surrounding tissues. The wall of
large blood vessels became irregular approximately 4 minutes after
doxorubicin administration (Fig. 3C, e-h, arrows). Blood vessels of
paclitaxel-injected mice (Fig. 3A i–l, 3B i–l, Fig. 3C i–l) resembled those
of saline-injected mice (Fig. 3A a–d, 3B a–d, Fig. 3C, a–d), where no
changes were observed in the structure or baseline dynamics of blood
vessels all throughout the measurement period. No fluorescence signal
was evident following administration of doxorubicin in mice that were
not injected previously with FITC-dextran.
Discussion
Of all the chemotherapy-induced side effects, the direct vascular
injury is the least characterized. The vascular endothelium is an
essential barrier that protects the tissues integrity, regulates the
homeostasis of water and solvents between the plasma and the
tissues and plays a role in the regulation of arterial vasomotor tone.
Impairment of the vascular endothelium may result in disintegra-
tion of the blood vessel wall and leakage of fluids from the blood
into the extracellular matrix, compromising organ function.
Studies addressing the vascular toxicity of certain chemothera-
peutic agents indicated that they were more toxic to endothelial
cells than to tumor cells [20]. Acute chemotherapy-induced
vascular damage, reflected as an increase in plasma level of von
Willibrand factor and in the intima-media thickness of the carotid
artery, was studied in vivo in patients suffering from testicular
cancer and treated with cisplatin-based chemotherapy [21].
Doxorubicin is used for treating a wide spectrum of malignan-
cies, and hence serves as a prototype in our study. Cardiotoxicity,
the most characterized deleterious effect of doxorubicin toxicity, is
cumulative dose-related [22]. It has been formerly implied that
endothelial damage may contribute to this pathogenesis; in acute
cases, the patient may suffer from hypotension, tachycardia and
arrhythmia, while an increased cumulative dose of doxorubicin
can cause congestive heart failure [23,24]. It has already been
documented that doxorubicin-treated rats develop marked ascites
[5] and that the in vitro permeability to albumin of bovine
pulmonary artery endothelial cells monolayer, 24 hours after
exposure to clinically relevant concentrations of doxorubicin, was
10 fold higher than that of control cells [25]. Several studies have
confirmed that doxorubicin induces oxidative stress, a condition
known to be toxic to endothelial cells, leading to loss of their
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doxorubicin on tissues excised from doxorubicin-injected animals.
An impaired endothelial-dependent vasodilatory response to
acetylcholine or adenosine was observed in rabbit and rat models
with doxorubicin–induced cardiomyopathy [5,28]. Brachial artery
reactivity, a marker for endothelial vasodilatation function,
Figure 1. Ultrasound contrast imaging of the ovarian blood volume. A. Representatives images of analyzed microbubbles contrast agent
intensity performed at a fixed region of interest (ROI). The Vevo ultrasound depicted a detailed imaging of the blood volume of mouse ovary before
and following administration of either saline (a–e) doxorubicin (f–j) or paclitaxel (k–o). Anatomy of the ovary in contrast mode (a,f,k); analysis of
contrast agent intensity determined using the appropriate VisualSonics software (b–e, g–j, l–o). The green colors indicate the presence of an
enhanced contrast agent). Baseline ovary blood volume (pre-treatment; b,g,l). Ovary blood volume 3 minutes (c,h,m), 10 minutes (d,i,n) and 20
minutes (e,j,o) following the IV injection of either chemotherapy or saline. B. Graphic representation of ovarian blood volume 3, 10 and 20 minutes
after doxorubicin (n=7), Paclitaxel (n=8) or saline (n=7) injection indicating a decrease in ovarian blood volume of doxorubicin treated mice (*
P,0.01). Saline-injected mice were standardized to 100% as a reference to chemotherapy-injected mice. Results are presented as mean6SD. The data
obtained from the images as presented in A, was presented as an Excell curve provided by the VisualSonics software.
doi:10.1371/journal.pone.0023492.g001
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patients that received at least 300 mg/m
2 of doxorubicin (or
daunorubicin) compared to control patients [11]. Furthermore,
brachial artery flow-mediated dilation in patients undergoing
doxorubicin based chemotherapy was markedly attenuated after a
single dose of doxorubicin [10]. Recently, it has been shown by
phase-contrast cardiovascular magnetic resonance measurements
of PW velocity and aortic distensibility that anthracyclins induce a
significant increase in thoracic aorta stiffness in patients receiving
anthracyclins compared to age and sex-matched controls [26].
We have previously studied the effect of doxorubicin on mice
ovaries, manifested by reduced ovulation rate and ovarian size, as
observed by high resolution MRI [29]. Our results indicated an
acute insult to the ovary, reflected by the presence of peri-ovarian
edema, encouraged us to further investigate the potential acute
vascular effect induced by doxorubicin administration [29].
In the current study, ovarian blood volume was visualized by
measuring the baseline concentration of injected microbubbles at
the designated blood vessels and the concentration throughout the
chemotherapeutic treatment. The use of ultrasound imaging in
Figure 2. Pulse-wave Doppler measurement of testicular and femoral arterial blood flow. Using PW Doppler mode, blood flow was
measured and quantified by analyzing Velocity-Time Integral (VTI) using the appropriate VisualSonics software. PW Doppler blood flow was
continuously monitored before and following doxorubicin administration. Saline-injected mice were standardized to 100% as a reference to
chemotherapy-injected mice. Results are presented as mean6SD. The data obtained from the images as presented in figure 1A, was presented as an
Excell curve provided by the VisualSonics software. A. Graphic representation of testicular blood flow 3, 6, 9, 12 and 15 minutes after doxorubicin
(n=8) or saline (n=7) injection indicating a rapid and constant fall in testicular blood flow of doxorubicin treated mice (* P,0.01). B. Graphic
representation of femoral blood flow volume 3, 10 and 20 minutes after doxorubicin (n=12), Paclitaxel (n=14) or saline (n=10) injection indicating a
rapid and constant fall in femoral blood flow of doxorubicin treated mice (* P,0.01).
doi:10.1371/journal.pone.0023492.g002
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use of PW Doppler as it allows assessment of tissue blood perfusion
in a larger ROI than PW Doppler and has a higher resolution
capability, both are essential in imaging of the small sized vessels of
the ovary. Detailed studies using intravital microscopy have shown
that microbubbles with a diameter of less than 5 mm are small
enough to allow their free movement through the bloodstream,
remain confined to the vasculature and are cleared from the blood
in about 15 minutes [30]. This methodology does not disrupt tissue
dynamics and physiological processes, and allows studies with
imaging at multiple time points. Both methods- ultrasound
imaging in conjunction with enhanced contrast agents and PW
Doppler were compared and validated [12,13].
A significant acute reduction in ovarian blood volume was
observed already 3 minutes after an IV injection of doxorubicin.
To explore whether this phenomenon is unique to the ovary, we
further studied the other gonad. We examined the vascular effect
in testes of male mice treated with doxorubicin. Here due to the
superficial location and dimension of the testicular vasculature we
employed the PW Doppler and revealed the same pattern of
vascular effect as in the ovaries. Subsequently, to further assess
whether this was an exclusive gonadal vascular effect or a
generalized effect appears in vessels of non end-organs, the
femoral vasculature was imaged as a reference. The significant
reduction in femoral arterial blood flow that remained compro-
mised throughout the experiment indicated a generalized
phenomenon. It is estimated that the non-significant decrease in
ovarian blood volume 10 and 20 minutes after doxorubicin
administration is due to technical reasons: since the ovary is
located within the peritoneal cavity, its blood flow measurement is
affected partially by the bowel movements. The measurements in
the later time points demonstrated a trend that was not statistically
significant probably due to above reason. The testicular blood flow
is not affected by those factors and hence is better displayed.
Nevertheless, we can postulate upon the testicular blood flow
dynamics that resembled those of the femoral vasculature that the
same pattern applies also for the ovarian vasculature, supported by
the acute significant decrease in blood volume. The acute vascular
effect of the testicular vessels may be attributed also by the unique
microcirculation of the testes. This architecture prones the testes to
pathophysiological states as varicocele, but also potentially to
exogenous toxicants. Former studies have characterized this
distinctive vasculature [31,32].
FCFM, equipped with laser scanning confocal technology,
enables real-time tracing of fluorescent agents within deep tissues
and produces smooth-motion video sequences of blood vessels in
vivo. It is used for studying the acute effect of the drug in situ [19].
We used FCFM, as previously reported [14] to study the acute
effect of doxorubicin on the blood vessels of the regional
microvasculature. The acute vascular effect observed by FCFM
that started approximately 2 minutes after doxorubicin adminis-
tration, differed according to blood vessels size: small vessels
(,15 mm diameter) suffered a constant narrowing already 2
minutes after doxorubicin injection and demonstrated a gradual
diminishment of the fluorescence signal from the imaged blood
vessels, with no apparent recovery during the next 8 minutes of
real-time imaging. In some experiments, ‘‘blurred’’ areas could be
spotted over the blood vessels walls, suggesting potential FITC-
dextran leakage. This phenomenon was less prominent in large
vessels (.15 mm diameter) that exhibited distortion of the blood
vessel wall, manifested by the appearance of irregular wall surface.
Paclitaxel, a different type of chemotherapeutic agent, did not
cause any vascular impairment in mice that could be evaluated by
either ultrasound or FCFM. We can therefore deduce that the
observed vascular toxicity is characteristic of doxorubicin.
In conclusion, we describe herein an innovative in vivo imaging
system capable of real-time capturing of chemotherapy-induced
acute vascular impairment in the same individual mouse
throughout an extended period of time. The acute reduction in
gonadal blood volume and femoral arterial blood flow, and the
impairment of the blood vessels’ wall may represent an acute
universal doxorubicin-related vascular toxicity, an initial event in
organ injury. The vascular impairment was sometimes followed by
altered barrier function of the blood vessels’ wall. The observed
phenomenon was significant for doxorubicin and was not evident
in paclitaxel treated mice.
The established experimental platform may serve for future
evaluation of potential agents designated to prevent doxorubicin-
induced vascular toxicity. Evidence for the role of several
mediators (as endothelial nitric oxide synthase (eNOS), NADPH
etc.) in the pathogenesis of doxorubicin-induced endothelial
dysfunction has already been proposed in previous studies
[10,25,33]. This platform may also be used to study in real-time
imaging the vascular effect of tyrosine kinase inhibitors (TKIs)
routinely used in the oncologic setting, that may have a potential
vascular impact as well as acute potential vascular effect of
targeted therapies. Elucidating the mechanism that lies at the core
of vascular toxicity might be useful in discovering biological keys
needed for decreasing the long term potential vascular complica-
tions in cancer survivors.
Supporting Information
Figure S1 Ultrasound contrast imaging of the ovarian
blood volume. B. Graphic representation of ovarian blood
volume 3, 10 and 20 minutes after doxorubicin (n=7), Paclitaxel
(n=8) or saline (n=7) injection indicating a decrease in ovarian
blood volume of doxorubicin treated mice (* P,0.01). Results are
presented as mean6SD of non-normalized values (saline injected
mice were not standardized as 100%). The data obtained from the
images as presented in A, was presented as an Excell curve
provided by the VisualSonics software.
(TIF)
Figure S2 Pulse-wave Doppler measurement of testicu-
lar and femoral arterial blood flow. Using PW Doppler
mode, blood flow was measured and quantified by analyzing
Velocity-Time Integral (VTI) using the appropriate VisualSonics
software. PW Doppler blood flow was continuously monitored
Figure 3. Ovarian and femoral microvasculature imaging. Representative images of FITC-dextran fluorescence signal in small (,15 mm
diameter) and large (.15 mm diameter) blood vessels. A continuous recording of ovarian and femoral microvasculature, of mice injected with FITC-
dextran (100 ml; 10 mg/ml) was obtained before and during an IV injection of doxorubicin (n=19), paclitaxel (n=8) or saline (n=9). A. The acute
vascular effect observed by FCFM in the small vessels, started approximately 2 minutes after doxorubicin administration (f, arrow), characterized by a
constant narrowing that caused a complete disappearance of the fluorescent signal from the imaged blood vessels, with no apparent recovery
during the next 8 minutes of real time imaging (g,h, arrows). B. In some experiments, a ‘‘blurred’’ area was evident over the blood vessel wall of
doxorubicin-injected mice (g,h, arrows) a few seconds after doxorubicin administration, suggesting a potential FITC leakage. C. Large vessels
exhibited distortion of the vessel wall, manifested by the appearance of irregular wall surface (h, arrows), 4 minutes after doxorubicin administration.
doi:10.1371/journal.pone.0023492.g003
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presented as mean6SD of non-normalized values (saline injected
mice were not standardized as 100%). The data obtained from the
images as presented in figure 1A, was presented as an Excell curve
provided by the VisualSonics software. A. Graphic representation
of testicular blood flow 3, 6, 9, 12 and 15 minutes after
doxorubicin (n=8) or saline (n=7) injection indicating a rapid
and constant fall in testicular blood flow of doxorubicin treated
mice (* P,0.01). B. Graphic representation of femoral blood flow
volume 3, 10 and 20 minutes after doxorubicin (n=12), Paclitaxel
(n=14) or saline (n=10) injection indicating a rapid and constant
fall in femoral blood flow of doxorubicin treated mice (* P,0.01).
(TIF)
Video S1 Ovarian and femoral microvasculature imag-
ing. Representative movies of FITC-dextran fluorescence signal
in small (,15 mm diameter) blood vessels. A continuous recording
of ovarian and femoral microvasculature, of mice injected with
FITC-dextran (100 ml; 10 mg/ml) was obtained starting at the
time of IV injection of doxorubicin. Small blood vessels exhibited a
constant narrowing approximately 2–5 minutes after doxorubicin
injection, up to a complete disappearance of the FITC-dextran
fluorescent signal, 8 minutes after treatment.
(AVI)
Video S2 Ovarian and femoral microvasculature imag-
ing. Representative movies of FITC-dextran fluorescence signal
in small (,15 mm diameter) blood vessels. A continuous recording
of ovarian and femoral microvasculature, of mice injected with
FITC-dextran (100 ml; 10 mg/ml) was obtained starting at the
time of IV injection of doxorubicin. Some small blood vessels
exhibited a "blurred" area over the vessel wall, suggesting a
potential FITC-dextran leakage.
(MPEG)
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